[1] |
ZHU Wenpeng, HAN Mengqi, WANG Yuxin, WANG Guoping.
Trends and Projections of Incidence and Mortality of Nasopharyngeal Carcinoma in China from 1990 to 2019
[J]. Chinese General Practice, 2023, 26(34): 4269-4276.
|
[2] |
ZHANG Jifang, CHEN Fang, TANG Jiawen, LI Hongliang.
Predictive Value of Tumor Budding and Tumor-infiltrating Lymphocytes on Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma
[J]. Chinese General Practice, 2023, 26(32): 4038-4042.
|
[3] |
ZHANG Dongli, SHEN Chong, ZHANG Weichuan, CHEN Haibin, ZHAO Jianjun.
Efficacy and Safety of Programmed Death-1/Programmed Death-1 Ligand Inhibitors in the Treatment of Renal Cell Cancer: a Meta-analysis
[J]. Chinese General Practice, 2023, 26(30): 3815-3822.
|
[4] |
YAN Ke, WEI Wanyi, LI Shuguang, YAO Weinan, DONG Jing, WANG Xiaobin, ZHANG Xueyuan, YANG Jie, SHEN Wenbin, ZHU Shuchai.
Effect of Consolidation Chemotherapy on Prognosis of StageⅡ-Ⅲ Esophageal Squamous Cell Carcinoma Patients Treated with Definitive Concurrent Chemotherapy and Radio-therapy
[J]. Chinese General Practice, 2023, 26(30): 3772-3779.
|
[5] |
YAN Ke, WEI Wanyi, DENG Wenzhao, SHEN Wenbin, LI Shuguang, DU Xingyu, ZHANG Xueyuan, YANG Jie, ZHU Shuchai.
Long-term Prognosis Analysis and Influencing Factors of Concurrent Chemotherapy and Radio-therapy for Cervical and Upper Thoracic Esophageal Squamous Cell Carcinoma
[J]. Chinese General Practice, 2023, 26(30): 3785-3790.
|
[6] |
CHEN Lunwen, ZHOU Yang, YAN Guodong, SHEN Yi, SUN Chen, CAI Wanli, CHU Minjie, XIAO Jing.
Risk of Malignant Tumor in Patients with Type 2 Diabetes: a Prospective Population-based Study
[J]. Chinese General Practice, 2023, 26(26): 3238-3245.
|
[7] |
JI Mengying, LI Yujing, CHEN Xing, DAI Huihua, SUN Ying.
Prediction Value of B-ultrasound with Tumor Markers for Malignant Transformation of Mucinous Ovarian Tumors
[J]. Chinese General Practice, 2023, 26(24): 3022-3027.
|
[8] |
ZHANG Yushuang, KONG Lingyang, GUAN Jiachang, LI Jianbo, WANG Yiran, WANG Yu, LI Jing.
16S rDNA Sequence Analysis of the Characteristics of Gut Flora in Patients with Esophageal Squamous Cell Carcinoma
[J]. Chinese General Practice, 2023, 26(20): 2496-2502.
|
[9] |
ZHAO Zewei, KANG Ning, GUO Fengli, WANG Zhongyu, ZHENG Xiangqian.
Effect of Aurora Kinase A Expression on Biochemical Cure in Patients after Medullary Thyroid Cancer Resection
[J]. Chinese General Practice, 2023, 26(20): 2508-2512.
|
[10] |
DENG Yuxuan, HE Li, SONG Zhiwang, JIANG Yanxia.
RET Proto-oncogene C634Y Mutation-associated Multiple Endocrine Adenomatosis Type 2A: a Case Report and Literature Review
[J]. Chinese General Practice, 2023, 26(14): 1794-1798.
|
[11] |
SONG Pingan, CHEN Xiaoliang, YAO Yuan, GAO Jin, YANG Yang, CUI Hongchun, ZHANG Yi.
Efficacy and Safety of PD-1 Inhibitors Monotherapy for Elderly Patients with Advanced Non-small Cell Lung Cancer
[J]. Chinese General Practice, 2023, 26(02): 241-247.
|
[12] |
Yan LI, Kunlun WANG, Hui YANG, Erjiang ZHAO, Bingxu LI, Shenglei LI, Xiaotao DONG, Ling YUAN.
Prognostic Value of Lactate Dehydrogenase in Advanced Esophageal Squamous Cell Carcinoma Patients with Immunotherapy
[J]. Chinese General Practice, 2022, 25(26): 3263-3269.
|
[13] |
Shunli LU, Jianping YU, Hongtao LI, Weikai CHEN, Andong LI, Chao CHEN, Qingyuan HE, Xiaopeng HAN.
Influencing Factors of Hypoparathyroidism in Patients with Differentiated Thyroid Carcinoma after Radical Thyroidectomy
[J]. Chinese General Practice, 2022, 25(23): 2869-2873.
|
[14] |
Jianhua XIE, Miaomiao LIU, Lili PENG, Rongsan ZHANG, Hongzhen ZHANG.
Systemic Immune-inflammatory-nutritional Index and Survival in Elderly NSCLC Patients with Non-surgical Treatment
[J]. Chinese General Practice, 2022, 25(17): 2082-2089.
|
[15] |
Gang YAO, Xinling CAO, Tao LI.
Predictive Value of C-reactive Protein to Albumin Ratio for Microvascular Invasion in Single Small Hepatocellular Carcinoma
[J]. Chinese General Practice, 2022, 25(12): 1429-1434.
|